Dishman Carbogen Amcis Ltd
NSE:DCAL

Watchlist Manager
Dishman Carbogen Amcis Ltd Logo
Dishman Carbogen Amcis Ltd
NSE:DCAL
Watchlist
Price: 267.9 INR -0.73%
Market Cap: 42B INR
Have any thoughts about
Dishman Carbogen Amcis Ltd?
Write Note

Dishman Carbogen Amcis Ltd
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dishman Carbogen Amcis Ltd
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Dishman Carbogen Amcis Ltd
NSE:DCAL
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Cash
â‚ą74.4m
CAGR 3-Years
-12%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vimta Labs Ltd
NSE:VIMTALABS
Cash
â‚ą123.5m
CAGR 3-Years
174%
CAGR 5-Years
79%
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Cash
â‚ą117.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dishman Carbogen Amcis Ltd
Glance View

Market Cap
42B INR
Industry
Life Sciences Tools & Services

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
257.4 INR
Overvaluation 4%
Intrinsic Value
Price

See Also

Back to Top